Topics

2/14/18

Department of Biochemistry researchers have changed the understanding of metal ion metabolism in mitochondria through a collaborative study whose results were published in Scientific Reports.

10/11/17

Daniel J. Kosman, PhD, SUNY Distinguished Professor of biochemistry, has been awarded a five-year, $1.96 million grant that may lead to advances in understanding the progression of Alzheimer’s disease.

7/19/17

Researchers in the Department of Physiology and Biophysics are studying genetic and epigenetic factors in Alzheimer’s disease to develop novel ways of restoring function to patients in the later stages of the neurodegenerative disorder.

7/5/17

To meet Western New York’s growing need for quality care for Alzheimer’s disease and related disorders, the Alzheimer’s Disease and Memory Disorders Center has expanded its clinics in Buffalo and Williamsville.

6/13/17

Surgeons and researchers sharing facilities in UB’s Clinical and Translational Science Institute and Kaleida Health’s Gates Vascular Institute (GVI) is resulting in collaboration, synergy and world-class innovation.

3/16/17

Using a database of 16,000 brain scans, Robert S. Miletich, MD, PhD, interim chair and professor of nuclear medicine, is helping to develop the field of nuclear neurology, which could launch a revolution in the diagnosis and treatment of brain diseases.

8/15/16

A multidisciplinary team of researchers is studying an embryonic stem cell gene that has the capacity to delay aging and the potential in some cases to reverse it.

5/12/16

Gabriela K. Popescu, PhD, professor of biochemistry, has been awarded a four-year, $1.37 million grant by the National Institutes of Health (NIH) to study modulation mechanisms in fast neurotransmitter brain receptors.

5/6/16

Researchers in the University at Buffalo’s Department of Neurology shared their findings through 30 presentations at the American Academy of Neurology’s 68th Annual Meeting.

3/11/16

A collaboration between the departments of Medicine and Neurology has been granted status as the Center for Excellence for Alzheimer’s disease in Western New York (CEAD WNY) through a five-year, $2.35 million state grant.

2/24/16

Richard M. Gronostajski, PhD, professor of biochemistry, has been awarded a three-year, $1 million grant to study neural stem cell (NSCs) therapies for a variety of brain insults and injuries.

10/14/15

Research by a biochemistry doctoral candidate is featured on the cover of the Journal of Neurochemistry for its potential to contribute to the treatment of neurodegenerative disorders.

9/11/15

A research team led by Richard M. Gronostajski, PhD, professor of biochemistry, has discovered a new way to generate oligodendrocytes. This method has the potential to enhance treatments for brain injury, multiple sclerosis, Alzheimer’s disease and more.

1/28/15
A University at Buffalo pilot study using high-resolution magnetic resonance imaging (MRI) links dietary habits with iron levels in the brain — a factor associated with various neurological conditions as well as aging.
12/5/13
Dementia and Alzheimer’s disease may be related to a vascular abnormality in the internal jugular veins, according to a revealing pilot study by an international research team, including University at Buffalo scientists.